Wuhan Zonke Optoelectronic Technology Co., Ltd.
News Center
Hand in hand to new heights, uniting forces for another leap forward.
Release time:2017-09-07
——The “Shumin Star” award from Zhongke Keli has been presented to Wuhan Meilai.
On August 30, 2017, our company’s flagship product—the first-ever solution for hormone-dependent dermatitis and allergic skin conditions—was launched. Soothing Star The event was held at Wuhan Meilai Plastic Surgery and Beauty Hospital, marking yet another occasion on which Meilai has chosen the “Shu Min Zhi Xing” brand.
A representative from Meilai Dermatology stated that the Shumin Zhi Xing boasts significant advantages in both clinical application and maintenance. Its stable hardware and reliably functioning software deliver impressive results in clinical treatment, with rapid, noticeable improvements for patients suffering from solar dermatitis, hormone‑dependent dermatitis, sensitive skin, and cosmetic‑induced dermatitis. Extensive clinical data have set the Shumin Zhi Xing apart from comparable products, firmly establishing it as a leading solution for allergic skin conditions and earning unanimous praise from physicians in Meilai’s dermatology department.
Zhongke Keli is committed to innovation and will further strengthen its R&D platform, deepen its channel network, and enhance its service system, offering professional solutions for hormone-dependent dermatitis and allergic skin conditions.
Related News